ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Human Embryo Panel Defines Acceptable Research For Funding

September 30, 1994

Court Orders NIH To Retract Electronic Annotations On Fisher Publications

March 24, 1995

In Brief: Henry Kaplan Dies Of Lung Cancer At 65; LED Development Of Hodgkin’s Disease Treatment

February 10, 1984

Steckel Object To Remarks By Korn Comparing Southern California Centers Unfavorably To NCCP Consortium

November 2, 1984

House Committee Approves $1.9 Bil. NCI Budget

July 31, 1992

In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles

November 4, 1983